Generics Group Urges High Court To Take Pay-For-Delay Case
A major generic pharmaceutical industry group on Monday urged the U.S. Supreme Court to grant Upsher-Smith Laboratories Inc.'s bid for review of a Third Circuit ruling that pay-for-delay pharmaceutical patent settlements...To view the full article, register now.
Already a subscriber? Click here to view full article